human fibroblast-derived dermal substitute

Clinical Research Poster

A Multicenter, Randomized, Single-blind Trial Comparing the Efficacy of Viable Cryopreserved Placental Membrane to Human Fibroblast-derived Dermal Substitute for the Treatment of Chronic Diabetic Foot Ulcers

10/16/2018

BACKGROUND: Randomized, controlled clinical trials (RCTs), the gold standard to determine treatment efficacy against a control, have demonstrated advantages of skin substitutes for the treatment of chronic diabetic foot ulcers (DFUs) in...

BACKGROUND: Randomized,...

10/16/2018

Wounds

Case Report

Treatment of Chronic Leg Ulcers with a Human Fibroblast-Derived Dermal Substitute: A Case Series of 114 Patients

03/10/2004

A. Hjerppe

M. Hjerppe

V. Autio

R. Raudasoja

A. Vaalasti

03/10/2004

Wounds

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

September 18 ⁠–⁠ September 20

September 20 ⁠–⁠ September 22

September 21 ⁠–⁠ September 22

September 30 ⁠–⁠ October 2

October 1 ⁠–⁠ October 2

October 2 ⁠–⁠ October 5

October 5 ⁠–⁠ October 6

October 14 ⁠–⁠ October 16

October 16 ⁠–⁠ October 19

October 19 ⁠–⁠ October 20

See Full Calendar

human fibroblast-derived dermal substitute

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products